SARS-CoV Peptide Antigen Negative control – 1mg NET peptide

Overview

The SARS-CoV Peptide Antigen Negative Control is a crucial component for researchers conducting HLA-A binding studies. Designed specifically to serve as a negative control, this peptide is derived from HBcAg and is H-2b-restricted, ensuring reliable results in your assays. Having a dependable negative control is essential for validating your findings and improving the accuracy of your research outcomes.

Key Features

• High purity peptide, ideal for HLA-A binding investigations.
• Specifically designed as a negative control for more accurate assay results.
• 1mg NET weight, providing ample quantity for multiple experiments.
• Derived from HBcAg, ensuring relevance in SARS-CoV studies.
• Compatible with various labeling and detection methods, enhancing flexibility in experimental design.

Specifications

FAQ

What is the purpose of the SARS-CoV Peptide Antigen Negative Control?

This peptide serves as a negative control in HLA-A binding studies, allowing researchers to confirm the specificity and effectiveness of their assay.

How is this peptide used in assays?

Researchers incorporate this negative control peptide alongside experimental samples to account for non-specific binding, ensuring the reliability of the results.

Can I find other peptides for similar applications?

Yes, AnaSpec offers a variety of peptides designed for different applications, including our selection of peptides tailored for advanced research.

Our SARS-CoV Peptide Antigen Negative Control provides the assurance you need in your HLA-A binding studies. Don’t compromise on accuracy, add this negative control to your cart today and enhance the reliability of your assay outcomes.

Related Products

• PKG Substrate [RKRSRAE], Glasstide
• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled